Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wayne Streilein

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Journal of Leukocyte Biology|July 30, 2003
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammationJ Wayne Streilein
Nature Reviews. Immunology|December 12, 2003
Ocular immune privilege: therapeutic opportunities from an experiment of natureJ Wayne Streilein
Cornea|March 22, 2005
MHC class I and II antigens as targets of rejection in penetrating keratoplasty in low- and high-risk mouse eyesHideya Osawa, J Wayne Streilein
Ocular Immunology and Inflammation|July 7, 2007
An analysis of graft-versus-host disease in Syrian hamsters. III. Hematological manifestations: description and studies in pathogenesis. 1972J Wayne Streilein, J Streilein
Ocular Immunology and Inflammation|October 30, 2004
Antigen-presenting cells are targets of regulatory T cells similar to those that mediate anterior chamber-associated immune deviationHidetoshi Yokoi, J Wayne Streilein
Investigative Ophthalmology & Visual Science|December 31, 2002
CD8+ T cell-mediated delayed rejection of orthotopic guinea pig cornea grafts in mice deficient in CD4+ T cellsRyotaro Higuchi, J Wayne Streilein
The Journal of Experimental Medicine|July 2, 2003
Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4Sunao Sugita, J Wayne Streilein
Investigative Ophthalmology & Visual Science|January 31, 2003
Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epitheliumJunko Hori, J Wayne Streilein
Immunology Today|October 8, 2014
ReplyJ Wayne Streilein, T Wegmann
Ocular Immunology and Inflammation|July 7, 2007
Recovery of activated cytotoxic T cells from minor H incompatible tumor graft rejection sites. 1989Bruce R Ksander, J Wayne Streilein
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Journal of Leukocyte Biology|July 30, 2003
Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammationJ Wayne Streilein
Nature Reviews. Immunology|December 12, 2003
Ocular immune privilege: therapeutic opportunities from an experiment of natureJ Wayne Streilein
Cornea|March 22, 2005
MHC class I and II antigens as targets of rejection in penetrating keratoplasty in low- and high-risk mouse eyesHideya Osawa, J Wayne Streilein
Ocular Immunology and Inflammation|July 7, 2007
An analysis of graft-versus-host disease in Syrian hamsters. III. Hematological manifestations: description and studies in pathogenesis. 1972J Wayne Streilein, J Streilein
Ocular Immunology and Inflammation|October 30, 2004
Antigen-presenting cells are targets of regulatory T cells similar to those that mediate anterior chamber-associated immune deviationHidetoshi Yokoi, J Wayne Streilein
Investigative Ophthalmology & Visual Science|December 31, 2002
CD8+ T cell-mediated delayed rejection of orthotopic guinea pig cornea grafts in mice deficient in CD4+ T cellsRyotaro Higuchi, J Wayne Streilein
The Journal of Experimental Medicine|July 2, 2003
Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4Sunao Sugita, J Wayne Streilein
Investigative Ophthalmology & Visual Science|January 31, 2003
Survival in high-risk eyes of epithelium-deprived orthotopic corneal allografts reconstituted in vitro with syngeneic epitheliumJunko Hori, J Wayne Streilein
Immunology Today|October 8, 2014
ReplyJ Wayne Streilein, T Wegmann
Ocular Immunology and Inflammation|July 7, 2007
Recovery of activated cytotoxic T cells from minor H incompatible tumor graft rejection sites. 1989Bruce R Ksander, J Wayne Streilein
Pageof 7